Details for New Drug Application (NDA): 011793
✉ Email this page to a colleague
The generic ingredient in ESIDRIX is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.
Summary for 011793
Tradename: | ESIDRIX |
Applicant: | Novartis |
Ingredient: | hydrochlorothiazide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 011793
Profile for product number 005
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 008
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 009
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription